Adroit BioMed launches Fortisil range of skincare products

PCI Pharma Services announces US $100 million investment in New England

Capabilities include the latest in sterile lyophilization and liquid filling technology to support global pharmaceutical supply chain, keeping pace with industry trends

The focus in FY 23 for most players would be international markets and ROW exports: Ankit Poddar, director, Candle Partners

Candle Partners, an investment banking & advisory service for M&A among others, has closed many deals in the healthcare space. Ankit Poddar, Director, Candle Partners spoke to Thomas C Thottathil, Editor, Indianpharmapost.com about the prospects for the industry.

Aarti Drugs Q4FY 22 consolidated revenue grew by 39 per cent YoY

The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt

Zydus receives tentative approval from USFDA for Selexipag tablets

The drug will be manufactured at the group's formulation facility at SEZ, Ahmedabad

Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore

The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings

Pfizer sets up global drug development centre in Chennai

The facility is among 12 centres established worldwide, and the first in Asia

Sona Group partners with Mycelium Biotechnology for R&D in Salem

As a global mushroom biotechnology group, Mycelium Biotechnology is engaged in mushroom growing, global distribution and offering biotechnology and nutraceutical solutions through global partners

India’s pharma exports grow by 103% since 2013-14

Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions

Lupin and Yabao announce strategic partnership in China

The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and policy measures